ANDA 205179, held by Epic Pharma LLC. Tobramycin Sulfate.
As of Nov 16, 2026, ANDA 205179 (Tobramycin Sulfate), held by Epic Pharma LLC, was first approved by FDA on Sep 16, 2014, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 16, 2014 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tobramycin SulfateEQ 40MG BASE/ML · injectable;injection | Tobramycin Sulfate | Discontinued |
| Feb 10, 2023 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jan 17, 2023 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jan 17, 2023 | Supplement 4Labeling · Standard review | Approved | None posted |
| Sep 16, 2014 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters